
Rosuvastatin (40mg)
Active composition
Rosuvastatin inhibits HMG-CoA reductase, decreasing cholesterol synthesis in the liver and increasing LDL receptor expression.
Medical applications
Hmgstat R 40 Tablet contains Rosuvastatin 40 mg, a potent lipid-lowering agent belonging to the statin class. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production and increased clearance of LDL particles from the bloodstream. This mechanism contributes to the reduction of atherosclerotic plaque formation and decreases the risk of cardiovascular events such as myocardial infarction, stroke, and angina in patients with or at risk for cardiovascular disease. Hmgstat R 40 is indicated as adjunctive therapy to diet and lifestyle modifications in adults with primary hyperlipidemia, familial hypercholesterolemia, and mixed dyslipidemia. It should be used with caution in patients with hepatic impairment and monitored for potential adverse effects including myopathy and elevated liver enzymes. Regular lipid profile assessments and liver function tests are recommended during therapy. Contraindications include active liver disease and pregnancy. Patient adherence to prescribed dosage and medical supervision is essential for optimal therapeutic outcomes.
Phenylpyrimidine derivatives
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Hmgstat R 40 Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
High Risk
Hmgstat R 40 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Hmgstat R 40 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Hmgstat R 40 Tablet may be needed. Please consult your doctor. Use of Hmgstat R 40 Tablet is not recommended in patients with severe kidney disease.
Exercise Caution
Hmgstat R 40 Tablet does not usually affect your ability to drive.
Consult Doctor
Hmgstat R 40 Tablet should be used with caution in patients with liver disease. Dose adjustment of Hmgstat R 40 Tablet may be needed. Please consult your doctor. Use of Hmgstat R 40 Tablet is not recommended in patients with severe liver disease and active liver disease.
Regular Checkup
0 reviews for Hmgstat R 40 Tablet

Rosuvastatin (40mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Rosuvastatin inhibits HMG-CoA reductase, decreasing cholesterol synthesis in the liver and increasing LDL receptor expression.
Medical applications
Hmgstat R 40 Tablet contains Rosuvastatin 40 mg, a potent lipid-lowering agent belonging to the statin class. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production and increased clearance of LDL particles from the bloodstream. This mechanism contributes to the reduction of atherosclerotic plaque formation and decreases the risk of cardiovascular events such as myocardial infarction, stroke, and angina in patients with or at risk for cardiovascular disease. Hmgstat R 40 is indicated as adjunctive therapy to diet and lifestyle modifications in adults with primary hyperlipidemia, familial hypercholesterolemia, and mixed dyslipidemia. It should be used with caution in patients with hepatic impairment and monitored for potential adverse effects including myopathy and elevated liver enzymes. Regular lipid profile assessments and liver function tests are recommended during therapy. Contraindications include active liver disease and pregnancy. Patient adherence to prescribed dosage and medical supervision is essential for optimal therapeutic outcomes.
Phenylpyrimidine derivatives
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Hmgstat R 40 Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
High Risk
Hmgstat R 40 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Hmgstat R 40 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Hmgstat R 40 Tablet may be needed. Please consult your doctor. Use of Hmgstat R 40 Tablet is not recommended in patients with severe kidney disease.
Exercise Caution
Hmgstat R 40 Tablet does not usually affect your ability to drive.
Consult Doctor
Hmgstat R 40 Tablet should be used with caution in patients with liver disease. Dose adjustment of Hmgstat R 40 Tablet may be needed. Please consult your doctor. Use of Hmgstat R 40 Tablet is not recommended in patients with severe liver disease and active liver disease.
Regular Checkup
0 reviews for Hmgstat R 40 Tablet















